Publications

This category contains 22 posts

Recurrence-free survival after sentinel node biopsy in melanoma?

Br J Dermatol. 2006 Sep; 155(3): 631-2Hayes AJ, Thomas JM

Cure of cutaneous melanoma.

BMJ. 2006 Apr 29; 332(7548): 987-8Thomas JM, Giblin V

The place of sentinel node biopsy in melanoma after the Multicenter Selective Lymphadenectomy Trial.

ANZ J Surg. 2006 Mar; 76(3): 98-9Thomas JM

Caution with sentinel node biopsy in cutaneous melanoma.

Br J Surg. 2006 Feb; 93(2): 129-30Thomas JM

Time for comprehensive reporting of MSLT-I.

Lancet Oncol. 2006 Jan; 7(1): 9-11; author reply 11-2Thomas JM

Sentinel lymph node biopsy in malignant melanoma.

BMJ. 2008 Apr 26; 336(7650): 902-3Thomas JM When melanoma spreads, it invariably does so by the lymphatic system. The first lymph node to be affected is called the sentinel node, and this node can be identified by injecting dye and a radioactive tracer at the primary tumour site. During sentinel lymph node biopsy, the sentinel [...]

The significance of melanoma micrometastases in the sentinel lymph node.

Eur J Surg Oncol. 2005 Dec; 31(10): 1103-4Giblin AV, Hayes AJ, Thomas JM

Dermatologists should exert a greater influence over sentinel lymph node biopsy for melanoma in the U.K.

Br J Dermatol. 2005 Jan; 152(1): 176-7Thomas JM, Giblin AV

Are there guidance issues relating to sentinel node biopsy for melanoma in the UK?

Br J Plast Surg. 2004 Oct; 57(7): 689-90; author reply 690-1Thomas JM, Clark MA

Dr. Herbert Lumley Snow, MD, MRCS (1847-1930): the original champion of elective lymph node dissection in melanoma.

Ann Surg Oncol. 2004 Sep; 11(9): 875-8Neuhaus SJ, Clark MA, Thomas JM Herbert Snow (1847-1930), a London surgeon with a particular interest in melanoma, was a controversial proponent of anticipatory gland excision well before acceptance of elective lymph node dissections. This article describes the work of Snow within a wider historical context.